Patent · US Active

Toxoplasma gondii vaccines and their use

US11969465B2 · kind B2 · utility

0Cited by

0References

9Claims

0Family size

Assignee

EMERGENT TRAVEL HEALTH INC. · US

Inventors

Rima McLeod · Chicago, US
Kamal El Bissati · Chicago, US
Ying Zhou · Shanghai, CN
Jeff ALEXANDER · Redwood City, US
Steve REED · Seattle, US
Peter BURKHARD · Mansfield Center, US
Mariane Bandeira Melo · Stoneham, US
Darrel IRVINE · Cambridge, US
Ron Weiss · Newton, US
Yuan Zhang · Edmond, US

Key dates

Filing date	Mar 11, 2022
Grant date	Apr 30, 2024
Priority date	—
Expiry date	Mar 11, 2042

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed herein are polynucleotides encoding multi-epitope polypeptides and assemblies thereof, and their use for treating or limiting Toxoplasma gondii infection.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.